|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||1.4301 - 1.4600|
|52-week range||1.3000 - 1.7650|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Wright Medical Group N.V. (NASDAQ:WMGI), NBT Bancorp Inc. (NASDAQ:NBTB), Carolina Financial Corporation (NASDAQ:CARO), Cohu, Inc. (NASDAQ:COHU), ProAssurance Corporation (NYSE:PRA), and At Home Group Inc. (NYSE:HOME), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Wright Medical (WMGI) forecasts improved sales, despite a plunge in revenues generated from the lower extremities business in fourth-quarter fiscal 2017.
Fourth Quarter 2017 Net Sales of Approximately $218 Million Full-Year 2017 Net Sales of Approximately $745 Million At High-End OfCompany’s Previously Provided 2017 Guidance Range Company to Present Today at J.P. Morgan Healthcare Conference at 7:30 a.m. Pacific Time
Wright Medical (WMGI) is focused on product innovation through research and development. However, lackluster international performance of the lower extremities segment is a matter of concern.
Wright Medical (WMGI) is focusing on product innovation through research and development. However, lackluster international performance of the Lower extremities segment is a matter of concern.
The Amsterdam-based company said it had a loss of $1.26 per share. Losses, adjusted to account for discontinued operations and non-recurring costs, were 16 cents per share. The results matched Wall Street ...